Haleon 

GBX391
1111
-GBX5.8-1.46% 今天

统计数据

当日最高
397.3
当日最低
387.3
52周最高
400.65
52周最低
308.37
成交量
14,986,903
平均成交量
18,098,656
市值
35.81B
市盈率
32.76
股息收益率
1.56%
股息
6.11

即将到来

股息

1.56%股息收益率
10年增长
N/A
5年增长
N/A
3年增长
N/A
1年增长
47.62%

收益

1Aug预期
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
0
10.32
20.65
30.97
预期每股收益
8.824391143911443
实际每股收益
8.933579335793361

人们还关注

此列表基于关注HLN.LSE的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。

关于

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
Show more...
首席执行官
Mr. Brian James McNamara
员工
25408
国家
GB
ISIN
GB00BMX86B70

上市公司